Abeona Therapeutics Inc. (ABEO): Price and Financial Metrics

ABEO POWR Grades

• Sentiment is the dimension where ABEO ranks best; there it ranks ahead of 83.86% of US stocks.
• The strongest trend for ABEO is in Growth, which has been heading down over the past 77 days.
• ABEO's current lowest rank is in the Momentum metric (where it is better than 9.53% of US stocks).

ABEO Stock Summary

• ABEO has a market capitalization of $31,084,964 -- more than approximately only 5.86% of US stocks.
• As for revenue growth, note that ABEO's revenue has grown -57.14% over the past 12 months; that beats the revenue growth of only 2.72% of US companies in our set.
• In terms of volatility of its share price, ABEO is more volatile than 98.51% of stocks we're observing.
• Stocks that are quantitatively similar to ABEO, based on their financial statements, market capitalization, and price volatility, are HTBX, CLSN, HRTX, SDGR, and ADVM.
• Visit ABEO's SEC page to see the company's official filings. To visit the company's web site, go to www.abeonatherapeutics.com.

ABEO Valuation Summary

• ABEO's EV/EBIT ratio is -2.4; this is 108.19% lower than that of the median Healthcare stock.
• Over the past 243 months, ABEO's price/sales ratio has gone down 6158.1.
• ABEO's price/sales ratio has moved down 6158.1 over the prior 243 months.

Below are key valuation metrics over time for ABEO.

ABEO Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -246.77%.
• Its 4 year cash and equivalents growth rate is now at 7.38%.
• Its 5 year price growth rate is now at 0.83%.

ABEO's revenue has moved up $2,000 over the prior 33 months.

The table below shows ABEO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	3	-37.018	-54.081
2021-06-30	10	-37.386	-54.274
2021-03-31	10	-35.372	-52.077
2020-12-31	10	-35.019	-84.234
2020-09-30	7	-47.655	-84.837
2020-06-30	0	-55.207	-94.972

ABEO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABEO has a Quality Grade of C, ranking ahead of 61.27% of graded US stocks.
• ABEO's asset turnover comes in at 0.069 -- ranking 293rd of 682 Pharmaceutical Products stocks.
• MCRB, NVAX, and VXRT are the stocks whose asset turnover ratios are most correlated with ABEO.

The table below shows ABEO's key quality metrics over time.